Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag

Abstract Poor graft function (PGF) is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Current treatment strategies include the use of growth factors, CD34+-selected stem cell boost, mesenchymal stem cell transfusion, and second allo-HSCT, but the...

Full description

Bibliographic Details
Main Authors: Cen Tang, Feng Chen, Danqing Kong, Qinfen Ma, Haiping Dai, Jia Yin, Zheng Li, Jia Chen, Xiaming Zhu, Xinliang Mao, Depei Wu, Xiaowen Tang
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Journal of Hematology & Oncology
Subjects:
Eltrombopag
Secondary poor graft function
Allogeneic hematopoietic stem cell transplantation
Online Access:http://link.springer.com/article/10.1186/s13045-018-0649-6

Internet

http://link.springer.com/article/10.1186/s13045-018-0649-6

Similar Items